Compounds > dacarbazine

dacarbazine and birinapant

dacarbazine has been researched along with birinapant in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boyd, AW; Byrne, AT; Day, BW; Flanagan, L; Kögel, D; Murray, DW; O'Brien, DF; Prehn, JH; Rehm, M; Salvucci, M; Stringer, BW; Tivnan, A; Zakaria, Z1
Alexopoulos, LG; Charles, EM; Hellwig, CT; Rehm, M; Rožanc, J; Vetma, V1

Other Studies

2 other study(ies) available for dacarbazine and birinapant

ArticleYear
Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant.
    British journal of cancer, 2016, Jan-19, Volume: 114, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Brain Neoplasms; Caspase 8; Cell Line, Tumor; Cell Survival; Dacarbazine; Dipeptides; Drug Resistance, Neoplasm; Flow Cytometry; Glioblastoma; Humans; In Vitro Techniques; Indoles; Inhibitor of Apoptosis Proteins; Mice; Mice, Inbred NOD; Mice, SCID; Microscopy, Phase-Contrast; Neoplasm Transplantation; Temozolomide; Xenograft Model Antitumor Assays

2016
Examining the In Vitro Efficacy of the IAP Antagonist Birinapant as a Single Agent or in Combination With Dacarbazine to Induce Melanoma Cell Death.
    Oncology research, 2017, Nov-02, Volume: 25, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Death; Cell Line, Tumor; Dacarbazine; Dipeptides; Humans; Indoles; Melanoma; Mutation; Skin Neoplasms

2017